Stocks Special Reports LICs Credit Technical Analysis Funds ETFs Tools SMSFs
Video Archive Article Archive
News Stocks Special Reports Funds ETFs Features Technical Analysis SMSFs Learn

Company News Summary

Phosphagenics Completes Pre-Clinical Study of Oxycodone/TPM Technology

20 Feb 2013  |  09:51:00  |  Associate analysts  |  Increase  |  Decrease  |  

Original announcement: Phosphagenics Further Expands Pain Portfolio

Phosphagenics has completed a pre-clinical study demonstrating that its oxycodone/TPM technology can reduce local pain without the need to deliver oxycodone into the bloodstream. The Company intends to commence clinical trials in Quarter 3 of 2013.

Please click here for full details

See more ASX300 News Announcements